Project Number 3RF1AG041845-02S5 Agency/Funding Organization NIA Funding Year 2017 View Full Project Details for Therapeutic Effect of Intranasal Insulin on Cognition, Function, and AD Biomarker Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator CRAFT, SUZANNE Principal Investigator First Name SUZANNE Principal Investigator Last Name CRAFT Awardee Organization WAKE FOREST UNIVERSITY HEALTH SCIENCES Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PA-10-067: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $1,145,191 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
